Viewing Study NCT04220892


Ignite Creation Date: 2025-12-24 @ 3:43 PM
Ignite Modification Date: 2025-12-28 @ 3:45 PM
Study NCT ID: NCT04220892
Status: WITHDRAWN
Last Update Posted: 2020-07-31
First Post: 2019-11-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High Grade Glioma
Sponsor: Jose Carrillo
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: JWCI-18-0702 (I3Y-US-I011)
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View